Ataxia–telangiectasia

From WikiMD's WELLNESSPEDIA

(Redirected from Louis-Bar syndrome)

Ataxia-telangiectasia (A-T) is a rare, neurodegenerative, autosomal recessive disease causing severe disability. A-T is characterized by progressive cerebellar ataxia, telangiectasia, immune defects, and a high rate of cancer.

Etymology[edit]

The term "ataxia" comes from the Greek word "ataxis" which means "without order or incoordination". The term "telangiectasia" is derived from the Greek words "telos" meaning "end", "angeion" meaning "vessel", and "ektasis" meaning "dilation". This refers to the dilation of end vessels found in patients with the condition.

Symptoms and Signs[edit]

The symptoms and signs of A-T are diverse and include severe progressive cerebellar ataxia, oculomotor apraxia, immune defects, recurrent sinopulmonary infections, and an increased risk of malignancies, particularly of lymphoid origin.

Causes[edit]

A-T is caused by a mutation in the ATM gene, which is involved in DNA repair. This mutation leads to a decrease in the production of the ATM protein, which is crucial for the normal function of several other proteins involved in the cell cycle control and DNA repair.

Diagnosis[edit]

Diagnosis of A-T is based on clinical features, laboratory findings of IgA deficiency and increased alpha-fetoprotein, and molecular genetic testing of the ATM gene.

Treatment[edit]

There is currently no cure for A-T. Treatment is supportive and includes physical and occupational therapy, gamma-globulin injections to boost the immune system, and high-dose vitamins.

Prognosis[edit]

The prognosis for individuals with A-T is poor. Most people with A-T become wheelchair-bound by their teens and do not survive past their early twenties.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.